JBIO
The table below shows Jade Biosciences, Inc.'s balance sheet by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $55.09M | $50.11M | $220.94M | $44.22M | $31.11M | $31.07M |
| Short-term investments | $256.21M | $148.80M | - | $31.99M | $57.62M | $73.13M |
| Receivables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Total current assets |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $318.52M |
| $201.36M |
| $222.98M |
| $77.37M |
| $90.61M |
| $110.76M |
| Property, plant & equipment | $157.00K | $176.00K | $147.00K | $2.00K | $14.00K | $232.00K |
| Goodwill | - | - | - | - | - | - |
| Total assets | $319.43M | $202.45M | $223.97M | $77.53M | $90.96M | $111.69M |
| Accounts payable | $3.98M | $1.35M | $7.59M | $69.00K | $908.00K | $4.18M |
| Total current liabilities | $22.29M | $22.36M | $21.62M | $2.42M | $10.31M | $17.02M |
| Long-term debt | - | - | - | - | - | - |
| Total liabilities | $22.97M | $23.10M | $22.41M | $2.49M | $10.47M | $17.30M |
| Retained earnings | -$214.76M | -$142.46M | -$117.28M | -$235.57M | -$227.62M | -$211.38M |
| Total equity | $296.46M | $179.35M | $201.56M | $75.05M | $80.49M | $94.40M |